T. Rowe Price Investment Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Buy
+1,216,358
New +$11.7M 0.01% 559
2026
Q1
Sell
-2,218,727
Closed -$26.1M 837
2025
Q4
$26.1M Buy
2,218,727
+912,788
+70% +$9.85M 0.02% 451
2025
Q3
$10.1M Sell
1,305,939
-1,955,279
-60% -$13.7M 0.01% 560
2025
Q2
$23.8M Sell
3,261,218
-55,951
-2% -$452K 0.02% 483
2025
Q1
$31.5M Sell
3,317,169
-3,210,942
-49% -$40.1M 0.02% 465
2024
Q4
$108M Sell
6,528,111
-13,289
-0.2% -$206K 0.07% 280
2024
Q3
$96.5M Sell
6,541,400
-188,883
-3% -$2.96M 0.06% 301
2024
Q2
$93.3M Sell
6,730,283
-127,298
-2% -$1.8M 0.06% 297
2024
Q1
$108M Buy
6,857,581
+475,066
+7% +$7.33M 0.07% 280
2023
Q4
$103M Buy
6,382,515
+856,296
+15% +$14M 0.07% 270
2023
Q3
$68M Buy
5,526,219
+466,633
+9% +$6.94M 0.05% 317
2023
Q2
$81.3M Buy
5,059,586
+158,146
+3% +$2.61M 0.06% 297
2023
Q1
$85.3M Buy
4,901,440
+1,984,505
+68% +$28.3M 0.06% 286
2022
Q4
$27M Buy
2,916,935
+348,026
+14% +$3.24M 0.02% 428
2022
Q3
$22.1M Buy
+2,568,909
New +$25.5M 0.02% 441

Other funds holding NEO

T. Rowe Price Investment Management's NEO Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in NeoGenomics (NEO) in Q2 2026: 1,216,358 shares worth $17.7M. The stake represents 0.01% of the portfolio and ranks #559 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in NEO as recently as Q4 2025.

T. Rowe Price Investment Management first reported a position in NEO in Q3 2022 and has held it in 15 quarters since. The position peaked at $108M in Q1 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • T. Rowe Price Investment Management held 1,216,358 shares of NeoGenomics worth $17.7M as of Q2 2026.
  • NeoGenomics was a new T. Rowe Price Investment Management position in Q2 2026.
  • NeoGenomics made up 0.01% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #559 holding.
  • T. Rowe Price Investment Management first reported a position in NeoGenomics in Q3 2022 and has held it in 15 quarters since.
  • T. Rowe Price Investment Management's NeoGenomics position peaked at $108M in Q1 2024.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.